Supercharged immune cells take on tough melanoma
NCT ID NCT05628883
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tested a new personalized therapy called TBio-4101 for people with advanced melanoma that had stopped responding to standard treatments. The therapy uses a patient's own tumor-fighting immune cells, which are collected, multiplied in the lab, and then infused back after a short course of chemotherapy. The goal was to see if this approach is safe and can shrink tumors in 17 participants with various types of melanoma.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TBio-4101 (a personalized immune cell therapy using the patient's own tumor-fighting T-cells)
- What this could lead to
- If successful, this could point toward a new treatment option for people with advanced melanoma that has not responded to standard therapies.
- What could go wrong
- This is a very early, small Phase 1 trial with only 17 participants, so results may not apply to everyone. The treatment involves strong chemotherapy and can cause serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACRAL MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- E-Learning could sharpen Doctors' eye for skin cancer
- Can tracking a rare eye cancer pave the way for new treatments?
- Can a new drug tame advanced solid tumors?
- Can a One-Two punch of immune boosters revive cancer treatment?
- Can a single eye injection shrink melanoma and save sight?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?